AlveoliX Competitors

Geron is a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer. Driven by urgency and guided by purpose, we aim to help patients live with more energy, fewer limitations, and more possibility in everyday life. We bring together deep expertise in telomerase biology with patient perspectives and insights from clinical research and real-world care to pursue what’s next for patients. Our telomerase inhibitor is the first and only of its kind approved in the U.S. and EU for certain patients with lower-risk myelodysplastic syndromes (LR-MDS) and we continue to explore the potential of telomerase inhibition beyond LR-MDS, including in myelofibrosis and other cancers. Our culture is shaped by curiosity, collaboration, accountability and the persistence that has defined Geron from the beginning. The determination that helped transform telomerase inhibition from a bold scientific idea into a clinically validated approach continues to guide how we think, work, and pursue what’s next for patients. Learn more about our science, our people and opportunities to join #TeamGeron at www.geron.com Geron’s Community Guidelines: https://www.geron.com/CommunityGuidelines/

InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug safety and efficacy testing in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to help researchers fuel a new era of drug discovery through comprehensive products and services for: - Liver safety - Liver disease - Islet Biology - Oncology & Immunology

Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, enabling researchers to accurately replicate human tissue function and disease biology through next generation in vitro models. From target discovery to IND submission, Emulate aims to ignite a new era in human health research—one that reduces animal testing, cuts drug development costs, and accelerates the delivery of life-saving treatments. Emulate’s Organ-Chip platforms, consumables, and organ models help the world’s leading pharmaceutical, biotech, and academic teams generate human-relevant data that advance safer, more effective therapies.